Skip to main content
Erschienen in: Acta Neuropathologica 1/2004

01.07.2004 | Regular Paper

Cerebral CD8+ lymphocytosis in HIV-1 infected patients with immune restoration induced by HAART

verfasst von: Robert F. Miller, Peter G. Isaacson, Margaret Hall-Craggs, Sebastian Lucas, Françoise Gray, Francesco Scaravilli, Shu F. An

Erschienen in: Acta Neuropathologica | Ausgabe 1/2004

Einloggen, um Zugang zu erhalten

Abstract

In HIV infected persons, highly active antiretroviral therapy (HAART) has reduced both the morbidity and incidence of several disorders. Its effects on direct HIV-induced damage to the CNS remain controversial. In addition, HAART may provoke an “immune reconstitution inflammatory syndrome” (IRIS). Herein we report two patients who, despite HAART, developed a diffuse encephalopathy. Their clinical, radiological and neuropathological features are described. Immunohistochemical and PCR analyses were used to detect HIV and to exclude other viruses in brain tissue. The unusual inflammatory reaction in the brain tissue was defined by immunohistochemistry. Both patients had advanced HIV disease with low CD4 counts and high HIV “viral loads” before starting HAART. In both, HAART induced an increase in CD4 count and a marked reduction in HIV viral load, which was accompanied, in patient one, by worsening of pre-existing, and, in patient two, by development of, acute encephalopathy. At post-mortem examination, the brain of patient one showed HIV encephalitis. In addition, the brains of both patients revealed HIV–DNA by PCR, diffuse microglial hyperplasia and massive and diffuse perivascular and intraparenchymal infiltration by CD8+/CD4− lymphocytes. We suggest that the rapid immune reconstitution induced by HAART in these two patients led to a redistribution of lymphocytes into peripheral blood. This was followed by recruitment of CD8+ lymphocytes into the brain, which resulted in the diffuse infiltration described. The appearances in patient two further suggest that HIV brain infection, even without encephalitis, is sufficient to trigger this response.
Literatur
1.
Zurück zum Zitat Albrecht H, Hoffmann C, Degen O, Stoehr A, Plettenberg A, Mertenskotter T, Eggers C, Stellbrink HJ (1998) Highly active antiretroviral therapy significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopathy. AIDS 12:1149–1154CrossRefPubMed Albrecht H, Hoffmann C, Degen O, Stoehr A, Plettenberg A, Mertenskotter T, Eggers C, Stellbrink HJ (1998) Highly active antiretroviral therapy significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopathy. AIDS 12:1149–1154CrossRefPubMed
2.
Zurück zum Zitat An SF, Ciardi A, Giometto B, Scaravilli T, Gray F, Scaravilli F (1996) Investigation on the expression of major histocompatibility complex class II and cytokines and detection of HIV-1 DNA within brains of asymptomatic and symptomatic HIV-1-positive patients. Acta Neuropathol 91:494–503CrossRefPubMed An SF, Ciardi A, Giometto B, Scaravilli T, Gray F, Scaravilli F (1996) Investigation on the expression of major histocompatibility complex class II and cytokines and detection of HIV-1 DNA within brains of asymptomatic and symptomatic HIV-1-positive patients. Acta Neuropathol 91:494–503CrossRefPubMed
3.
Zurück zum Zitat An SF, Giometto B, Scaravilli F (1996) HIV-1 DNA in brains in AIDS and pre-AIDS: correlation with the stage of disease. Ann Neurol 40:611–617PubMed An SF, Giometto B, Scaravilli F (1996) HIV-1 DNA in brains in AIDS and pre-AIDS: correlation with the stage of disease. Ann Neurol 40:611–617PubMed
4.
Zurück zum Zitat An SF, Groves M, Gray F, Scaravilli F (1999) Early entry and widespread cellular involvement of HIV-1 DNA in brains of HIV-1 positive asymptomatic individuals. J Neuropathol Exp Neurol 58:1156–1162 An SF, Groves M, Gray F, Scaravilli F (1999) Early entry and widespread cellular involvement of HIV-1 DNA in brains of HIV-1 positive asymptomatic individuals. J Neuropathol Exp Neurol 58:1156–1162
5.
Zurück zum Zitat Autran B, Carcelain G, Li TS, Blanc C, Mathez D, Tubiana R, Katlama C, Debre P, Leibowitch J (1997) Positive effects of combined antiretroviral therapy on CD4+ T cells homeostasis and function in advanced HIV cases. Science 277:112–116CrossRefPubMed Autran B, Carcelain G, Li TS, Blanc C, Mathez D, Tubiana R, Katlama C, Debre P, Leibowitch J (1997) Positive effects of combined antiretroviral therapy on CD4+ T cells homeostasis and function in advanced HIV cases. Science 277:112–116CrossRefPubMed
6.
Zurück zum Zitat Brodt HR, Kamps BS, Gute P, Knupp B, Staszewski S, Helm EB (1997) Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy. AIDS 11:1731–1738CrossRefPubMed Brodt HR, Kamps BS, Gute P, Knupp B, Staszewski S, Helm EB (1997) Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy. AIDS 11:1731–1738CrossRefPubMed
7.
Zurück zum Zitat Carr A, Cooper DA (1997) Restoration of immunity to chronic hepatitis B infection in HIV-infected patients on protease inhibitor. Lancet 349:995–996CrossRef Carr A, Cooper DA (1997) Restoration of immunity to chronic hepatitis B infection in HIV-infected patients on protease inhibitor. Lancet 349:995–996CrossRef
8.
Zurück zum Zitat Carr A, Emery S, Kelleher A, Law M, Cooper DA (1996) CD8+ lymphocyte responses to antiretroviral therapy of HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol 13:320–326PubMed Carr A, Emery S, Kelleher A, Law M, Cooper DA (1996) CD8+ lymphocyte responses to antiretroviral therapy of HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol 13:320–326PubMed
9.
Zurück zum Zitat Carr A, Samaras K, Chisholm DJ, Cooper DA (1998) Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia and insulin resistance. Lancet 351:1881–1883CrossRefPubMed Carr A, Samaras K, Chisholm DJ, Cooper DA (1998) Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia and insulin resistance. Lancet 351:1881–1883CrossRefPubMed
10.
Zurück zum Zitat Clifford DB, Yannoutsos C, Glicksman M, Simpson DM, Singer EJ, Piliero PJ, Marra CM, Francis GS, McArthur JC, Tyler KL, Tselis AC, Hyslop NE (1999) HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy. Neurology 52:623–625PubMed Clifford DB, Yannoutsos C, Glicksman M, Simpson DM, Singer EJ, Piliero PJ, Marra CM, Francis GS, McArthur JC, Tyler KL, Tselis AC, Hyslop NE (1999) HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy. Neurology 52:623–625PubMed
11.
Zurück zum Zitat Crump JA, Tyrer MJ, Lloyd-Owen SJ, Han LY, Lipman MC, Johnson MA (1998) Miliary tuberculosis with paradoxical expansion of intracranial tuberculomas complicating immunodeficiency virus infection in a patient receiving highly active antiretroviral therapy. Clin Infect Dis 26:1008–1009PubMed Crump JA, Tyrer MJ, Lloyd-Owen SJ, Han LY, Lipman MC, Johnson MA (1998) Miliary tuberculosis with paradoxical expansion of intracranial tuberculomas complicating immunodeficiency virus infection in a patient receiving highly active antiretroviral therapy. Clin Infect Dis 26:1008–1009PubMed
12.
Zurück zum Zitat DeSimone JA, Pomerantz RJ, Babinchak TJ (2000) Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy. Ann Intern Med 133:447–454PubMed DeSimone JA, Pomerantz RJ, Babinchak TJ (2000) Inflammatory reactions in HIV-1-infected persons after initiation of highly active antiretroviral therapy. Ann Intern Med 133:447–454PubMed
13.
Zurück zum Zitat Foudraine NA, Hovenkamp E, Notermans DW, Meenhorst PL, Klein MR, Lange JM, Miedema F, Reiss P (1999) Immunopathology as a result of highly active antiretroviral therapy in HIV-1-infected patients. AIDS 13:177–184CrossRefPubMed Foudraine NA, Hovenkamp E, Notermans DW, Meenhorst PL, Klein MR, Lange JM, Miedema F, Reiss P (1999) Immunopathology as a result of highly active antiretroviral therapy in HIV-1-infected patients. AIDS 13:177–184CrossRefPubMed
14.
Zurück zum Zitat Gay FW, Drye TJ, Dick GW, Esiri MM (1997) The application of multifactorial cluster analysis in the staging of plaques in early multiple sclerosis. Identification and characterisation of the primary demyelinating lesion. Brain 120:1461–1483CrossRefPubMed Gay FW, Drye TJ, Dick GW, Esiri MM (1997) The application of multifactorial cluster analysis in the staging of plaques in early multiple sclerosis. Identification and characterisation of the primary demyelinating lesion. Brain 120:1461–1483CrossRefPubMed
15.
Zurück zum Zitat Hartung H-P, Grossman RI (2001) ADEM: distinct disease or part of MS spectrum? Neurology 56:1257–1260PubMed Hartung H-P, Grossman RI (2001) ADEM: distinct disease or part of MS spectrum? Neurology 56:1257–1260PubMed
16.
Zurück zum Zitat Hoffmann C, Tabrizian S, Wolf E, Eggers C, Stoehr A, Plettenberg A, Buhk T, Stellbrink HJ, Horst HA, Jager H, Rosenkranz T (2001) Survival of AIDS patients with primary central nervous system lymphoma is dramatically improved by HAART-induced immune recovery. AIDS 15:2119–2127CrossRefPubMed Hoffmann C, Tabrizian S, Wolf E, Eggers C, Stoehr A, Plettenberg A, Buhk T, Stellbrink HJ, Horst HA, Jager H, Rosenkranz T (2001) Survival of AIDS patients with primary central nervous system lymphoma is dramatically improved by HAART-induced immune recovery. AIDS 15:2119–2127CrossRefPubMed
17.
Zurück zum Zitat Jacobson MA, Zegans M, Pavan PR, O’Donnell JJ, Sattler F, Rao N, Owens S, Pollard R (1997) Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy. Lancet 349:1143–1145CrossRefPubMed Jacobson MA, Zegans M, Pavan PR, O’Donnell JJ, Sattler F, Rao N, Owens S, Pollard R (1997) Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy. Lancet 349:1143–1145CrossRefPubMed
18.
Zurück zum Zitat Jellinger KA, Setinek U, Drilicek M, Bohm G, Steurer A, Lintner F (2000) Neuropathology and general autopsy findings in AIDS during the last 15 years. Acta Neuropathol 100:213–220CrossRefPubMed Jellinger KA, Setinek U, Drilicek M, Bohm G, Steurer A, Lintner F (2000) Neuropathology and general autopsy findings in AIDS during the last 15 years. Acta Neuropathol 100:213–220CrossRefPubMed
19.
Zurück zum Zitat John M, Flexman J, French MA (1998) Hepatitis C virus-associated hepatitis following treatment of HIV-infected patients with HIV protease inhibitors: an immune restoration disease. AIDS 12:2289–2293PubMed John M, Flexman J, French MA (1998) Hepatitis C virus-associated hepatitis following treatment of HIV-infected patients with HIV protease inhibitors: an immune restoration disease. AIDS 12:2289–2293PubMed
20.
Zurück zum Zitat Kelleher AD, Carr A, Zaunders J, Cooper DA (1996) Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir. J Infect Dis 173:321–329PubMed Kelleher AD, Carr A, Zaunders J, Cooper DA (1996) Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir. J Infect Dis 173:321–329PubMed
21.
Zurück zum Zitat King MD, Perlino CA, Cinnamon J, Jernigan JA (2002) Paradoxical recurrent meningitis following therapy of cryptococcal meningitis: an immune reconstitution syndrome after initiation of highly active antiretroviral therapy. AIDS 13:724–726CrossRef King MD, Perlino CA, Cinnamon J, Jernigan JA (2002) Paradoxical recurrent meningitis following therapy of cryptococcal meningitis: an immune reconstitution syndrome after initiation of highly active antiretroviral therapy. AIDS 13:724–726CrossRef
22.
Zurück zum Zitat Lacabaratz-Porret C, Urrutia A, Doisne JM, Goujard C, Deveau C, Dalod M, Meyer L, Rouzioux C, Delfraissy JF, Venet A, Sinet M (2003) Impact of antiretroviral therapy and changes in virus load on human immunodeficiency virus (HIV)-specific T cell responses in primary HIV infection. J Infect Dis 187:748–757CrossRefPubMed Lacabaratz-Porret C, Urrutia A, Doisne JM, Goujard C, Deveau C, Dalod M, Meyer L, Rouzioux C, Delfraissy JF, Venet A, Sinet M (2003) Impact of antiretroviral therapy and changes in virus load on human immunodeficiency virus (HIV)-specific T cell responses in primary HIV infection. J Infect Dis 187:748–757CrossRefPubMed
23.
Zurück zum Zitat Lange CG, Lederman MM (2003) Immune reconstitution with antiretroviral therapies in chronic HIV-1 infection. J Antimicrob Chemother 51:1–4CrossRef Lange CG, Lederman MM (2003) Immune reconstitution with antiretroviral therapies in chronic HIV-1 infection. J Antimicrob Chemother 51:1–4CrossRef
24.
Zurück zum Zitat Langford TD, Letendre SL, Marcotte TD, Ellis RJ, McCutchan JA, Grant I, Mallory ME, Hansen LA, Archibald S, Jernigan T, Masliah E (2002) Severe, demyelinating leukoencephalopathy in AIDS patients on antiretroviral therapy. AIDS 16:1019–1029CrossRefPubMed Langford TD, Letendre SL, Marcotte TD, Ellis RJ, McCutchan JA, Grant I, Mallory ME, Hansen LA, Archibald S, Jernigan T, Masliah E (2002) Severe, demyelinating leukoencephalopathy in AIDS patients on antiretroviral therapy. AIDS 16:1019–1029CrossRefPubMed
25.
Zurück zum Zitat Martinez E, Gatell J, Moran Y, Aznar E, Buira E, Guelar A, Mallolas J, Soriano E (1998) High incidence of Herpes zoster in patients with AIDS soon after therapy with protease inhibitors. Clin Infect Dis 27:1510–1513PubMed Martinez E, Gatell J, Moran Y, Aznar E, Buira E, Guelar A, Mallolas J, Soriano E (1998) High incidence of Herpes zoster in patients with AIDS soon after therapy with protease inhibitors. Clin Infect Dis 27:1510–1513PubMed
26.
Zurück zum Zitat Maschke M, Kastrup O, Esser S, Ross B, Hengge U, Hufnagel A (2000) Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART). J Neurol Neurosurg Psychiat 69:376–380CrossRefPubMed Maschke M, Kastrup O, Esser S, Ross B, Hengge U, Hufnagel A (2000) Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART). J Neurol Neurosurg Psychiat 69:376–380CrossRefPubMed
27.
Zurück zum Zitat Miralles P, Berenguer J, Lacruz C, Cosin J, Lopez JC, Padilla B, Munoz L, Garcia-de-Viedma D (2001) Inflammatory reactions in progressive multifocal leukoencephalopathy after highly active antiretroviral therapy. AIDS 15:1900–1902CrossRefPubMed Miralles P, Berenguer J, Lacruz C, Cosin J, Lopez JC, Padilla B, Munoz L, Garcia-de-Viedma D (2001) Inflammatory reactions in progressive multifocal leukoencephalopathy after highly active antiretroviral therapy. AIDS 15:1900–1902CrossRefPubMed
28.
Zurück zum Zitat Neumann H, Medana IM, Bauer J, Lassmann H (2002) Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases. TINS 25:313–319CrossRefPubMed Neumann H, Medana IM, Bauer J, Lassmann H (2002) Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases. TINS 25:313–319CrossRefPubMed
29.
Zurück zum Zitat Pakker NG, Ross MTL, van Leeuwen R, de Jong MD, Koot M, Reiss P, Lange JM, Miedema F, Danner SA, Schellekens PT (1997) Patterns of T cell repopulation, virus load reduction and restoration of T cell function in HIV-infected persons during therapy with different antiretrovirals. J Acquir Immune Defic Syndr Hum Retrovirol 16:318–326PubMed Pakker NG, Ross MTL, van Leeuwen R, de Jong MD, Koot M, Reiss P, Lange JM, Miedema F, Danner SA, Schellekens PT (1997) Patterns of T cell repopulation, virus load reduction and restoration of T cell function in HIV-infected persons during therapy with different antiretrovirals. J Acquir Immune Defic Syndr Hum Retrovirol 16:318–326PubMed
30.
Zurück zum Zitat Petito C, Adkins B, McCarthy M, Robert B, Khamis I (2003) CD4+ and CD8+ cells accumulate in the brains of acquired immunodeficiency syndrome patients with human immunodeficiency virus encephalitis. J Neurovirol 9:36–44PubMed Petito C, Adkins B, McCarthy M, Robert B, Khamis I (2003) CD4+ and CD8+ cells accumulate in the brains of acquired immunodeficiency syndrome patients with human immunodeficiency virus encephalitis. J Neurovirol 9:36–44PubMed
31.
Zurück zum Zitat Poluektova LY, Munn DH, Persidsky Y, Gendelman HE (2002) Generation of cytotoxic T cells against virus-infected human brain macrophages in a murine model of HIV-1 encephalitis. J Immunol 168:3941–3949PubMed Poluektova LY, Munn DH, Persidsky Y, Gendelman HE (2002) Generation of cytotoxic T cells against virus-infected human brain macrophages in a murine model of HIV-1 encephalitis. J Immunol 168:3941–3949PubMed
32.
Zurück zum Zitat Sacktor NC, Lyles RH, Skolasky R, Anderson DE, McArthur JC, McFarlane G et al. (1999) The multicenter AIDS Cohort Study. HIV-1-related neurological disease incidence changes in the era of highly active antiretroviral therapy. Neurology 52:A252–A253 Sacktor NC, Lyles RH, Skolasky R, Anderson DE, McArthur JC, McFarlane G et al. (1999) The multicenter AIDS Cohort Study. HIV-1-related neurological disease incidence changes in the era of highly active antiretroviral therapy. Neurology 52:A252–A253
33.
Zurück zum Zitat Sacktor N, Lyles RH, Skolasky R, Kleeberger C, Selnes OA, Miller EN, Becker JT, Cohen B, McArthur JC (2001) HIV associated neurologic disease incidence changes: multicenter AIDS cohort study, 1990–1998. Neurology 56:257–260PubMed Sacktor N, Lyles RH, Skolasky R, Kleeberger C, Selnes OA, Miller EN, Becker JT, Cohen B, McArthur JC (2001) HIV associated neurologic disease incidence changes: multicenter AIDS cohort study, 1990–1998. Neurology 56:257–260PubMed
34.
Zurück zum Zitat Sacktor NC, Skolasky RL, Lyles RH, Esposito D, Selnes OA, McArthur JC (2000) Improvement of HIV-associated motor slowing after antiretroviral therapy including protease inhibitors. J Neurovirol 6:84–88PubMed Sacktor NC, Skolasky RL, Lyles RH, Esposito D, Selnes OA, McArthur JC (2000) Improvement of HIV-associated motor slowing after antiretroviral therapy including protease inhibitors. J Neurovirol 6:84–88PubMed
35.
Zurück zum Zitat Safdar A, Rubocki RJ, Horvath JA, Narayan KK, Waldron RL (2002) Fatal immune restoration disease in human immunodeficiency virus type-1-infected patients with progressive multifocal leukoencephalopathy: impact of antiretroviral therapy-associated immune reconstitution. Clin Infect Dis 35:1250–1257CrossRefPubMed Safdar A, Rubocki RJ, Horvath JA, Narayan KK, Waldron RL (2002) Fatal immune restoration disease in human immunodeficiency virus type-1-infected patients with progressive multifocal leukoencephalopathy: impact of antiretroviral therapy-associated immune reconstitution. Clin Infect Dis 35:1250–1257CrossRefPubMed
36.
Zurück zum Zitat Sanchez-Ramon S, Bellon JM, Resino S, Canto-Nogues C, Gurbindo D, Ramos JT, Munoz-Fernandez MA (2003) Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children. Pediatrics 111:E168–E175PubMed Sanchez-Ramon S, Bellon JM, Resino S, Canto-Nogues C, Gurbindo D, Ramos JT, Munoz-Fernandez MA (2003) Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children. Pediatrics 111:E168–E175PubMed
37.
Zurück zum Zitat Shelburne SA, Hamill RJ, Rodriguez-Barradas MC, Greenberg SB, Atmar RL, Musher DW, Gathe JC Jr, Visnegarwala F, Trautner BW (2002) Immune reconstruction inflammatory syndrome. Emergence of a unique syndrome during Highly Active Antiretroviral Therapy. Medicine 81:213–227CrossRefPubMed Shelburne SA, Hamill RJ, Rodriguez-Barradas MC, Greenberg SB, Atmar RL, Musher DW, Gathe JC Jr, Visnegarwala F, Trautner BW (2002) Immune reconstruction inflammatory syndrome. Emergence of a unique syndrome during Highly Active Antiretroviral Therapy. Medicine 81:213–227CrossRefPubMed
38.
Zurück zum Zitat Smyth MJ, Kelly JM, Sutton VR, Davis JE, Browne KA, Sayers TJ, Trapani JA (2001) Unlocking the secrets of cytoplasmic granule proteins. J Leukoc Biol 70:18–29PubMed Smyth MJ, Kelly JM, Sutton VR, Davis JE, Browne KA, Sayers TJ, Trapani JA (2001) Unlocking the secrets of cytoplasmic granule proteins. J Leukoc Biol 70:18–29PubMed
39.
Zurück zum Zitat Tantisiriwat W, Tebas P, Clifford DB, Powderly WG, Fichtenbaum CJ (1998) Progressive multifocal leukoencephalopathy in patients with AIDS receiving highly active antiretroviral therapy. Clin Infect Dis 28:1152–1154 Tantisiriwat W, Tebas P, Clifford DB, Powderly WG, Fichtenbaum CJ (1998) Progressive multifocal leukoencephalopathy in patients with AIDS receiving highly active antiretroviral therapy. Clin Infect Dis 28:1152–1154
40.
Zurück zum Zitat Wendel KA, McArthur JC (2003) Acute meningoencephalitis in chronic human immunodeficiency virus (HIV) infection: putative central nervous system escape of HIV replication. Clin Infect Dis 37:1107–1111CrossRefPubMed Wendel KA, McArthur JC (2003) Acute meningoencephalitis in chronic human immunodeficiency virus (HIV) infection: putative central nervous system escape of HIV replication. Clin Infect Dis 37:1107–1111CrossRefPubMed
41.
Zurück zum Zitat Wood ML, MacGinley R, Eisen DP, Allworth AM (1998) HIV combination therapy: partial immune restitution unmasking latent cryptococcal infection. AIDS 12:1491–1494CrossRefPubMed Wood ML, MacGinley R, Eisen DP, Allworth AM (1998) HIV combination therapy: partial immune restitution unmasking latent cryptococcal infection. AIDS 12:1491–1494CrossRefPubMed
Metadaten
Titel
Cerebral CD8+ lymphocytosis in HIV-1 infected patients with immune restoration induced by HAART
verfasst von
Robert F. Miller
Peter G. Isaacson
Margaret Hall-Craggs
Sebastian Lucas
Françoise Gray
Francesco Scaravilli
Shu F. An
Publikationsdatum
01.07.2004
Verlag
Springer-Verlag
Erschienen in
Acta Neuropathologica / Ausgabe 1/2004
Print ISSN: 0001-6322
Elektronische ISSN: 1432-0533
DOI
https://doi.org/10.1007/s00401-004-0852-0

Weitere Artikel der Ausgabe 1/2004

Acta Neuropathologica 1/2004 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Wartezeit nicht kürzer, aber Arbeit flexibler

Psychotherapie Medizin aktuell

Fünf Jahren nach der Neugestaltung der Psychotherapie-Richtlinie wurden jetzt die Effekte der vorgenommenen Änderungen ausgewertet. Das Hauptziel der Novellierung war eine kürzere Wartezeit auf Therapieplätze. Dieses Ziel wurde nicht erreicht, es gab jedoch positive Auswirkungen auf andere Bereiche.

„Restriktion auf vier Wochen Therapie bei Schlaflosigkeit ist absurd!“

06.05.2024 Insomnie Nachrichten

Chronische Insomnie als eigenständiges Krankheitsbild ernst nehmen und adäquat nach dem aktuellen Forschungsstand behandeln: Das forderte der Schlafmediziner Dr. Dieter Kunz von der Berliner Charité beim Praxis Update.

Stuhltransfusion könnte Fortschreiten von Parkinson-Symptomen bremsen

03.05.2024 Parkinson-Krankheit Nachrichten

Kann eine frühzeitige Stuhltransplantation das Fortschreiten von Parkinson-Symptomen verlangsamen? Die Ergebnisse einer randomisierten Phase-2-Studie scheinen dafür zu sprechen.

Frühe Tranexamsäure-Therapie nützt wenig bei Hirnblutungen

02.05.2024 Hirnblutung Nachrichten

Erhalten Personen mit einer spontanen Hirnblutung innerhalb von zwei Stunden nach Symptombeginn eine Tranexamsäure-Therapie, kann dies weder die Hämatomexpansion eindämmen noch die Mortalität senken.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.